Maynard Um
-
-
-
-
-
-
-
Acrivon Therapeutics (ACRV) Reiterated at Market Outperform by Citizens Ahead of Update
-
-
-
-
-
-
-
Acrivon's (ACRV) ORR, mDoR Results are Competitive - Citizens
-
-
-
-
-
-
-
Acrivon Therapeutics, Inc. (ACRV) Tops Q1 EPS by 50c
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Acrivon Therapeutics Inc (ACRV)
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Acrivon Therapeutics Inc (ACRV)
-
-
-
-
-
-
470,379 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


